JPMorgan China Growth & Income (JCGI) Competitors

JPMorgan China Growth & Income logo
GBX 275.60 +2.60 (+0.95%)
As of 03:16 AM Eastern

JCGI vs. JEO, JUP, APEO, RICA, and OCI

Should you buy JPMorgan China Growth & Income stock or one of its competitors? MarketBeat compares JPMorgan China Growth & Income with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with JPMorgan China Growth & Income include European Opportunities Trust (JEO), Jupiter Fund Management (JUP), abrdn Private Equity Opportunities (APEO), Ruffer Investment (RICA), and Oakley Capital Investments (OCI). These companies are all part of the "asset management" industry.

How does JPMorgan China Growth & Income compare to European Opportunities Trust?

JPMorgan China Growth & Income (LON:JCGI) and European Opportunities Trust (LON:JEO) are both small-cap asset management industry companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

JPMorgan China Growth & Income has a net margin of 60,650.00% compared to European Opportunities Trust's net margin of 0.00%. JPMorgan China Growth & Income's return on equity of 10.57% beat European Opportunities Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan China Growth & Income60,650.00% 10.57% -21.06%
European Opportunities Trust N/A N/A N/A

JPMorgan China Growth & Income pays an annual dividend of GBX 10.92 per share and has a dividend yield of 4.0%. European Opportunities Trust pays an annual dividend of GBX 0.04 per share. JPMorgan China Growth & Income pays out 14.3% of its earnings in the form of a dividend. European Opportunities Trust pays out -0.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

5.1% of JPMorgan China Growth & Income shares are held by institutional investors. 0.2% of JPMorgan China Growth & Income shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, JPMorgan China Growth & Income's average media sentiment score of 0.00 equaled European Opportunities Trust'saverage media sentiment score.

Company Overall Sentiment
JPMorgan China Growth & Income Neutral
European Opportunities Trust Neutral

JPMorgan China Growth & Income has higher revenue and earnings than European Opportunities Trust. European Opportunities Trust is trading at a lower price-to-earnings ratio than JPMorgan China Growth & Income, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan China Growth & Income£64.40M3.46£6.34M£76.323.61
European Opportunities Trust-£62.33M0.00N/A-£65.20N/A

Summary

JPMorgan China Growth & Income beats European Opportunities Trust on 8 of the 10 factors compared between the two stocks.

How does JPMorgan China Growth & Income compare to Jupiter Fund Management?

JPMorgan China Growth & Income (LON:JCGI) and Jupiter Fund Management (LON:JUP) are both small-cap financial services companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

In the previous week, Jupiter Fund Management's average media sentiment score of 1.11 beat JPMorgan China Growth & Income's score of 0.00 indicating that Jupiter Fund Management is being referred to more favorably in the news media.

Company Overall Sentiment
JPMorgan China Growth & Income Neutral
Jupiter Fund Management Positive

JPMorgan China Growth & Income has a net margin of 60,650.00% compared to Jupiter Fund Management's net margin of 21.19%. Jupiter Fund Management's return on equity of 11.49% beat JPMorgan China Growth & Income's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan China Growth & Income60,650.00% 10.57% -21.06%
Jupiter Fund Management 21.19%11.49%4.00%

Jupiter Fund Management has a consensus target price of GBX 155.33, suggesting a potential downside of 5.86%. Given Jupiter Fund Management's stronger consensus rating and higher possible upside, analysts clearly believe Jupiter Fund Management is more favorable than JPMorgan China Growth & Income.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JPMorgan China Growth & Income
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Jupiter Fund Management
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

5.1% of JPMorgan China Growth & Income shares are owned by institutional investors. Comparatively, 36.9% of Jupiter Fund Management shares are owned by institutional investors. 0.2% of JPMorgan China Growth & Income shares are owned by insiders. Comparatively, 4.1% of Jupiter Fund Management shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

JPMorgan China Growth & Income pays an annual dividend of GBX 10.92 per share and has a dividend yield of 4.0%. Jupiter Fund Management pays an annual dividend of GBX 4.30 per share and has a dividend yield of 2.6%. JPMorgan China Growth & Income pays out 14.3% of its earnings in the form of a dividend. Jupiter Fund Management pays out 24.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. JPMorgan China Growth & Income is clearly the better dividend stock, given its higher yield and lower payout ratio.

JPMorgan China Growth & Income has higher earnings, but lower revenue than Jupiter Fund Management. JPMorgan China Growth & Income is trading at a lower price-to-earnings ratio than Jupiter Fund Management, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan China Growth & Income£64.40M3.46£6.34M£76.323.61
Jupiter Fund Management£465.70M1.78-£8.84M£17.909.22

JPMorgan China Growth & Income has a beta of 0.8422751, indicating that its share price is 16% less volatile than the broader market. Comparatively, Jupiter Fund Management has a beta of 1.295, indicating that its share price is 30% more volatile than the broader market.

Summary

Jupiter Fund Management beats JPMorgan China Growth & Income on 11 of the 17 factors compared between the two stocks.

How does JPMorgan China Growth & Income compare to abrdn Private Equity Opportunities?

abrdn Private Equity Opportunities (LON:APEO) and JPMorgan China Growth & Income (LON:JCGI) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

abrdn Private Equity Opportunities pays an annual dividend of GBX 17 per share. JPMorgan China Growth & Income pays an annual dividend of GBX 10.92 per share and has a dividend yield of 4.0%. abrdn Private Equity Opportunities pays out 4,250.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. JPMorgan China Growth & Income pays out 14.3% of its earnings in the form of a dividend. JPMorgan China Growth & Income is clearly the better dividend stock, given its higher yield and lower payout ratio.

JPMorgan China Growth & Income has a net margin of 60,650.00% compared to abrdn Private Equity Opportunities' net margin of 76.01%. JPMorgan China Growth & Income's return on equity of 10.57% beat abrdn Private Equity Opportunities' return on equity.

Company Net Margins Return on Equity Return on Assets
abrdn Private Equity Opportunities76.01% 5.18% 3.35%
JPMorgan China Growth & Income 60,650.00%10.57%-21.06%

72.2% of abrdn Private Equity Opportunities shares are owned by institutional investors. Comparatively, 5.1% of JPMorgan China Growth & Income shares are owned by institutional investors. 3.7% of abrdn Private Equity Opportunities shares are owned by insiders. Comparatively, 0.2% of JPMorgan China Growth & Income shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

abrdn Private Equity Opportunities has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, JPMorgan China Growth & Income has a beta of 0.8422751, meaning that its stock price is 16% less volatile than the broader market.

abrdn Private Equity Opportunities has higher revenue and earnings than JPMorgan China Growth & Income. abrdn Private Equity Opportunities is trading at a lower price-to-earnings ratio than JPMorgan China Growth & Income, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Private Equity Opportunities£80.21M0.00£60.96M£0.40N/A
JPMorgan China Growth & Income£64.40M3.46£6.34M£76.323.61

In the previous week, abrdn Private Equity Opportunities' average media sentiment score of 0.00 equaled JPMorgan China Growth & Income'saverage media sentiment score.

Company Overall Sentiment
abrdn Private Equity Opportunities Neutral
JPMorgan China Growth & Income Neutral

Summary

abrdn Private Equity Opportunities and JPMorgan China Growth & Income tied by winning 6 of the 12 factors compared between the two stocks.

How does JPMorgan China Growth & Income compare to Ruffer Investment?

Ruffer Investment (LON:RICA) and JPMorgan China Growth & Income (LON:JCGI) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Ruffer Investment's average media sentiment score of 0.00 equaled JPMorgan China Growth & Income'saverage media sentiment score.

Company Overall Sentiment
Ruffer Investment Neutral
JPMorgan China Growth & Income Neutral

Ruffer Investment pays an annual dividend of GBX 5.95 per share and has a dividend yield of 2.0%. JPMorgan China Growth & Income pays an annual dividend of GBX 10.92 per share and has a dividend yield of 4.0%. Ruffer Investment pays out 47.2% of its earnings in the form of a dividend. JPMorgan China Growth & Income pays out 14.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. JPMorgan China Growth & Income is clearly the better dividend stock, given its higher yield and lower payout ratio.

Ruffer Investment has higher earnings, but lower revenue than JPMorgan China Growth & Income. JPMorgan China Growth & Income is trading at a lower price-to-earnings ratio than Ruffer Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ruffer Investment£44.42M19.49£8.78M£12.6123.24
JPMorgan China Growth & Income£64.40M3.46£6.34M£76.323.61

JPMorgan China Growth & Income has a net margin of 60,650.00% compared to Ruffer Investment's net margin of 62.53%. JPMorgan China Growth & Income's return on equity of 10.57% beat Ruffer Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
Ruffer Investment62.53% 4.37% 0.45%
JPMorgan China Growth & Income 60,650.00%10.57%-21.06%

8.1% of Ruffer Investment shares are held by institutional investors. Comparatively, 5.1% of JPMorgan China Growth & Income shares are held by institutional investors. 0.4% of Ruffer Investment shares are held by insiders. Comparatively, 0.2% of JPMorgan China Growth & Income shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Ruffer Investment has a beta of 0.203, meaning that its share price is 80% less volatile than the broader market. Comparatively, JPMorgan China Growth & Income has a beta of 0.8422751, meaning that its share price is 16% less volatile than the broader market.

Summary

JPMorgan China Growth & Income beats Ruffer Investment on 7 of the 13 factors compared between the two stocks.

How does JPMorgan China Growth & Income compare to Oakley Capital Investments?

JPMorgan China Growth & Income (LON:JCGI) and Oakley Capital Investments (LON:OCI) are both small-cap asset management industry companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Oakley Capital Investments has higher revenue and earnings than JPMorgan China Growth & Income. JPMorgan China Growth & Income is trading at a lower price-to-earnings ratio than Oakley Capital Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan China Growth & Income£64.40M3.46£6.34M£76.323.61
Oakley Capital Investments£66.57M11.93£88.03M£34.0014.12

JPMorgan China Growth & Income pays an annual dividend of GBX 10.92 per share and has a dividend yield of 4.0%. Oakley Capital Investments pays an annual dividend of GBX 2.25 per share and has a dividend yield of 0.5%. JPMorgan China Growth & Income pays out 14.3% of its earnings in the form of a dividend. Oakley Capital Investments pays out 6.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

5.1% of JPMorgan China Growth & Income shares are held by institutional investors. Comparatively, 25.6% of Oakley Capital Investments shares are held by institutional investors. 0.2% of JPMorgan China Growth & Income shares are held by company insiders. Comparatively, 13.0% of Oakley Capital Investments shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

JPMorgan China Growth & Income has a beta of 0.8422751, indicating that its stock price is 16% less volatile than the broader market. Comparatively, Oakley Capital Investments has a beta of 0.73994994, indicating that its stock price is 26% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JPMorgan China Growth & Income
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Oakley Capital Investments
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

JPMorgan China Growth & Income has a net margin of 60,650.00% compared to Oakley Capital Investments' net margin of 74.73%. JPMorgan China Growth & Income's return on equity of 10.57% beat Oakley Capital Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan China Growth & Income60,650.00% 10.57% -21.06%
Oakley Capital Investments 74.73%4.67%4.33%

In the previous week, Oakley Capital Investments had 2 more articles in the media than JPMorgan China Growth & Income. MarketBeat recorded 2 mentions for Oakley Capital Investments and 0 mentions for JPMorgan China Growth & Income. Oakley Capital Investments' average media sentiment score of 0.56 beat JPMorgan China Growth & Income's score of 0.00 indicating that Oakley Capital Investments is being referred to more favorably in the news media.

Company Overall Sentiment
JPMorgan China Growth & Income Neutral
Oakley Capital Investments Positive

Summary

Oakley Capital Investments beats JPMorgan China Growth & Income on 12 of the 17 factors compared between the two stocks.

Get JPMorgan China Growth & Income News Delivered to You Automatically

Sign up to receive the latest news and ratings for JCGI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JCGI vs. The Competition

MetricJPMorgan China Growth & IncomeAsset Management IndustryFinancial SectorLON Exchange
Market Cap£222.62M£2.45B£6.07B£2.78B
Dividend Yield4.90%6.03%5.27%6.16%
P/E Ratio3.6125.8716.31365.73
Price / Sales3.462,082.031,100.9086,253.70
Price / Cash148.7760.1684.9827.85
Price / Book1.011.376.657.92
Net Income£6.34M£264.62M£1.13B£5.89B
7 Day Performance0.40%-0.48%-0.23%-0.92%
1 Month Performance-1.57%-0.14%1.00%-0.75%
1 Year Performance17.78%9.73%19.70%69.29%

JPMorgan China Growth & Income Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JCGI
JPMorgan China Growth & Income
N/AGBX 275.60
+1.0%
N/A+17.7%£222.62M£64.40M3.61N/A
JEO
European Opportunities Trust
N/AN/AN/AN/A£886.70M-£62.33MN/AN/A
JUP
Jupiter Fund Management
1.8764 of 5 stars
GBX 175.62
-0.2%
GBX 155.33
-11.6%
+75.9%£881.58M£465.70M9.81522
APEO
abrdn Private Equity Opportunities
N/AN/AN/AN/A£880.29M£80.21M1,435.00N/A
RICA
Ruffer Investment
N/AGBX 295
-1.5%
N/A+3.1%£871.62M£44.42M23.39N/A

Related Companies and Tools


This page (LON:JCGI) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners